Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention
about
Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug deliveryPharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention.Short communication: cheminformatics analysis to identify predictors of antiviral drug penetration into the female genital tractPharmacogenomics of antimicrobial agents.HIV pre-exposure prophylaxis: mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model.Pharmacokinetics of antiretrovirals in mucosal tissuePharmacodynamic Activity of Dapivirine and Maraviroc Single Entity and Combination Topical Gels for HIV-1 PreventionDifferential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis.Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women.Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial.Effect of HIV infection and menopause status on raltegravir pharmacokinetics in the blood and genital tract.Expression, regulation, and function of drug transporters in cervicovaginal tissues of a mouse model used for microbicide testing.Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies.Multimodal analysis of drug transporter expression in gastrointestinal tissue.Drug transporter gene expression in human colorectal tissue and cell lines: modulation with antiretrovirals for microbicide optimization.Analytical Advances in the Ex Vivo Challenge Efficacy Assay.Mucosal tissue pharmacokinetics of the integrase inhibitor raltegravir in a humanized mouse model: Implications for HIV pre-exposure prophylaxis.HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities.Haplotype Analysis of MDR1 and Risk for Cervical Cancer in Northeastern ThailandSingle-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues.Differences in Local and Systemic TFV PK Among Premenopausal Versus Postmenopausal Women Exposed to TFV 1% Vaginal Gel.Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir Against Repeated Rectal SHIV Exposures in Macaques.
P2860
Q28081272-4C6747BF-49F6-4A2C-94BB-3BDA2BEB3B14Q33888718-5BAB4A9B-7D43-47FD-8DE7-3B4CFA8F737EQ34399668-EC529713-FA02-4FA7-8B4B-6189C16B9731Q34977413-A505AF35-2D00-4C2E-9CCC-8AEF0D9072BEQ35794988-DDB2CB78-4F61-4727-82E8-E25E9B2FAA6DQ35838594-E2A66634-4EA4-49C3-A0A7-6783B717F61AQ36143276-DE6E2FEA-3538-436F-861A-47E77F617CD6Q36644606-EA945CDF-21EE-41FB-A676-330BD626AF37Q37114554-9CEC6DA2-7CB3-479B-B1D9-090E764FA86AQ37116845-9C318974-1901-4D7D-9F65-C96CB90B9885Q37592039-01977D51-0058-4038-8046-227CE6124C1CQ37716218-42343CEB-ED29-4120-AA6D-E013A3D64D5BQ38256787-F2D133A7-6927-4B59-A6F0-150C28C0E009Q38738700-2655B163-A08D-42E4-9F99-79AF6F05EAFDQ38823939-9FBAF37A-47B1-4162-9C0F-330024025497Q39189916-BDE85F5D-BDDB-4BC2-BCEC-7AC255035192Q40103140-F4072A45-58EB-42D3-8A55-E87982FA2384Q40256176-A21A7AC1-A495-4F48-B68D-3B9E2E5AF5A6Q42672848-70D68253-6835-4933-84D4-335195DE3872Q47806688-8185BAE2-6D09-40C8-BF0F-C90005292D99Q49926142-F1C449BB-A27F-4474-81E8-D5E9C2EDFD58Q54202671-55A644CE-EAA8-4044-8C6D-CB11676B2C88
P2860
Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Expression of six drug transpo ...... disposition in HIV prevention
@ast
Expression of six drug transpo ...... disposition in HIV prevention
@en
type
label
Expression of six drug transpo ...... disposition in HIV prevention
@ast
Expression of six drug transpo ...... disposition in HIV prevention
@en
prefLabel
Expression of six drug transpo ...... disposition in HIV prevention
@ast
Expression of six drug transpo ...... disposition in HIV prevention
@en
P2093
P2860
P356
P1476
Expression of six drug transpo ...... disposition in HIV prevention
@en
P2093
Angela D M Kashuba
Deanna L Kroetz
Elizabeth Geller
Heather M A Prince
Katie Mollan
Kristine B Patterson
Michelle Mathews
Stephanie Mathews
Yuri Fedoriw
P2860
P304
P356
10.1002/JCPH.248
P577
2014-01-02T00:00:00Z